HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Analysis of patients with nonambulatory neuromuscular scoliosis surgically treated to the pelvis with intraoperative halo-femoral traction.

AbstractSTUDY DESIGN:
Retrospective case-control study.
OBJECTIVES:
To compare patients treated with and without intraoperative halo-femoral traction to assess neuromuscular spinal deformity correction as well as the safety of the technique.
SUMMARY OF BACKGROUND DATA:
Optimal sitting balance can be achieved in nonambulatory neuromuscular patients with pelvic obliquity by maneuvering a Galveston-type rod or inserting screws into the iliac wings; however, this is often clinically challenging because of the small, soft bone-stock in the pelvis of these patients.
METHODS:
A total of 40 patients with nonambulatory neuromuscular scoliosis were treated surgically with a T2 or T3-sacrum instrumented posterior spinal fusion. There were 20 patients (12 who underwent posterior spinal fusion-alone and 8 anterior/posterior spinal fusion) who had intraoperative halo-femoral traction performed unilaterally on the high side iliac wing compared to a control group of 20 patients (15 who underwent posterior spinal fusion-alone and 5 anterior/posterior spinal fusion) operatively treated without halo-femoral traction. Each group had 14 patients with spastic (cerebral palsy) scoliosis, and 6 with flaccid (muscular dystrophy) scoliosis deformities. Minimum follow-up for all patients was 2 years (range 3-12).
RESULTS:
Preoperative lumbar scoliosis averaged 87 degrees (range 30 degrees-141 degrees) in the halo-femoral traction group and 67 degrees (range 28 degrees-108 degrees) in the control group (P = 0.012). Postoperative lumbar Cobb decreased to 35 degrees (range 15 degrees-60 degrees) in the halo-femoral traction group and 32 degrees (range 4 degrees-66 degrees) in the control group (P = 0.181). Preoperative pelvic obliquity averaged 26 degrees (range 8 degrees-47 degrees) in the halo-femoral traction group and 17 degrees (range 8 degrees-44 degrees) in the control group (P = 0.017); postoperative averaged 6 degrees (range 1 degrees-23 degrees) in the halo-femoral traction group and 7 degrees (range 0 degrees-27 degrees) in the control group. Average pelvic obliquity correction was 78% in the halo-femoral traction group and 52% in the control group (P = 0.001). There were no intraoperative or postoperative halo-femoral traction apparatus-related complications noted (pin cut-out, femoral fractures, pin-sight infections, etc.).
CONCLUSIONS:
Intraoperative use of halo-femoral traction during the surgical treatment of patients with nonambulatory neuromuscular scoliosis provided significantly improved lumbar curve and pelvic obliquity correction. Intraoperative halo-femoral traction had no associated perioperative complications.
AuthorsKatsushi Takeshita, Lawrence G Lenke, Keith H Bridwell, Yongjung J Kim, Brenda Sides, Marsha Hensley
JournalSpine (Spine (Phila Pa 1976)) Vol. 31 Issue 20 Pg. 2381-5 (Sep 15 2006) ISSN: 1528-1159 [Electronic] United States
PMID16985468 (Publication Type: Clinical Trial, Comparative Study, Journal Article)
Topics
  • Adolescent
  • Adult
  • Bone Nails
  • Cerebral Palsy (complications, pathology, surgery)
  • Child
  • Female
  • Femur (surgery)
  • Humans
  • Internal Fixators
  • Intraoperative Period
  • Male
  • Muscular Dystrophies (complications, pathology, surgery)
  • Neuromuscular Diseases (complications, pathology, surgery)
  • Pelvis (diagnostic imaging, pathology, surgery)
  • Radiography
  • Sacrum (diagnostic imaging, pathology, surgery)
  • Scoliosis (etiology, pathology, surgery)
  • Spinal Fusion (instrumentation)
  • Thoracic Vertebrae (diagnostic imaging, pathology, surgery)
  • Traction (instrumentation, methods)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: